With continued research, MSC-Exos have the potential to revolutionize treatment strategies for conditions associated with iron dysregulation and oxidative stress
If you miss a dose, the next step depends on how much time has passed
The FDA has sent dozens of warning letters to telehealth companies this year over misleading ads for compounded GLP-1s, many of which implied the drugs were FDA-approved
This applies to all research peptide vendors, not just Simple Peptide
Appropriate trained and qualified staff may need to be deployed to these locations when time permits, and the capacity of general healthcare staff capacity to provide mental health and psychosocial support should be increased (see the mhGAP Humanitarian Intervention Guide)
Currently, GLP-1 medications should not replace conventional disease-modifying antirheumatic drugs (DMARDs) or biologic therapies, which remain the gold standard for RA treatment